Copper Rock Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-34,880
Closed -$3.89M 103
2017
Q2
$3.89M Buy
34,880
+4,025
+13% +$450K 0.25% 69
2017
Q1
$3.09M Buy
30,855
+6,495
+27% +$694K 0.2% 54
2016
Q4
$2.62M Buy
24,360
+1,459
+6% +$171K 0.17% 58
2016
Q3
$2.83M Buy
22,901
+1,941
+9% +$229K 0.18% 60
2016
Q2
$2.23M Buy
20,960
+10,560
+102% +$1.23M 0.17% 56
2016
Q1
$1.19M Buy
10,400
+2,530
+32% +$297K 0.1% 53
2015
Q4
$1.12M Sell
7,870
-4,880
-38% -$563K 0.09% 52
2015
Q3
$1.15M Sell
12,750
-350
-3% -$36.9K 0.1% 47
2015
Q2
$1.51M Sell
13,100
-450
-3% -$47.3K 0.11% 50
2015
Q1
$1.29M Buy
+13,550
New +$1.01M 0.11% 50

Other funds holding CBPO

Copper Rock Capital Partners's CBPO Position: Q3 2017 in Review

Copper Rock Capital Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 34,880 shares — an estimated $3.89M sold.

Copper Rock Capital Partners first reported a position in CBPO in Q1 2015 and held it in 10 quarters. The position peaked at $3.89M in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Copper Rock Capital Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Copper Rock Capital Partners sold 34,880 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $3.89M.
  • Copper Rock Capital Partners first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 10 quarters.
  • Copper Rock Capital Partners's China Biologic Products Holdings, Inc. position peaked at $3.89M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Copper Rock Capital Partners's 13F filing for Q3 2017, filed 11 Oct 2017.